Show simple item record

Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: A randomised, single-blind, placebo-controlled, phase 2 trial

dc.contributor.authorMartinón Torres, Federico 
dc.date.accessioned2017-06-07T07:18:24Z
dc.date.available2017-06-07T07:18:24Z
dc.date.issued2012
dc.identifier.issn1473-3099
dc.identifier.urihttp://hdl.handle.net/20.500.11940/4914
dc.language.isoeng
dc.titleSafety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: A randomised, single-blind, placebo-controlled, phase 2 trial
dc.typeArtigoes
dc.authorsophosRichmond, P C
dc.authorsophosMarshall, H S
dc.authorsophosNissen, M D
dc.authorsophosJiang, Q
dc.authorsophosJansen, K U
dc.authorsophosGarcés-Sánchez, M
dc.authorsophosMartinón-Torres, F
dc.authorsophosBeeslaar, J
dc.authorsophosSzenborn, L
dc.authorsophosWysocki, J
dc.authorsophosEiden, J
dc.authorsophosHarris, S L
dc.authorsophosJones, T R
dc.authorsophosPerez, J L
dc.authorsophosGarces-Sanchez, M
dc.authorsophosMartinon-Torres, F
dc.identifier.doi10.1016/S1473-3099%2812%2970087-7
dc.identifier.isiWOS:000306941200024
dc.identifier.pmid22569484
dc.identifier.sophos8030
dc.issue.number8
dc.journal.titleLANCET INFECTIOUS DISEASES
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Pediatría
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago::IDIS.- Instituto de investigaciones sanitarias de Santiago
dc.page.initial597
dc.page.final607
dc.rights.accessRightsopenAccess
dc.typesophosArtículo Original
dc.volume.number12


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record